Elon Musk has been feuding with President Trump over a bill the president is championing that, among other things, cuts incentives for electric vehicles and solar energy that benefit Musk’s ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

"It’s time for me to give someone else the chance to experience the joy of leading this program, and we have found the right ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Here are some highlights from the first half of the year: ...

Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

Tech funds enjoyed a strong recovery while bonds suffered, according to FE fundinfo fund performance data for May. US trade ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

How a bold pitch on a black bear hunt turned into a lasting alliance—and a ticket to the inner circle of Trump's Washington.

President Trump’s America First policies have fueled trillions in U.S. investments, creating jobs and boosting domestic ...

About 15% of colon cancers are dMMR, which confers resistance to chemotherapy. ICIs have FDA approval for metastatic dMMR ...